Class information for:
Level 1: TAFI//CARBOXYPEPTIDASE U//THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
15791 622 36.3 84%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
261 18876 PROTEIN C//ACTIVATED PROTEIN C//TISSUE FACTOR

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 TAFI Author keyword 200 77% 22% 134
2 CARBOXYPEPTIDASE U Author keyword 112 97% 5% 32
3 THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR Author keyword 94 69% 13% 81
4 PROCARBOXYPEPTIDASE U Author keyword 26 100% 2% 11
5 THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR TAFI Author keyword 25 73% 3% 19
6 TAFIA Author keyword 15 82% 1% 9
7 CARBOXYPEPTIDASE R Author keyword 14 100% 1% 7
8 PROCPU Author keyword 11 100% 1% 6
9 THROMBIN ACTIVABLE FIBRINOLYSIS INHIBITOR Author keyword 8 100% 1% 5
10 SECT GEN EXPT PATHOL Address 7 57% 1% 8

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 TAFI 200 77% 22% 134 Search TAFI Search TAFI
2 CARBOXYPEPTIDASE U 112 97% 5% 32 Search CARBOXYPEPTIDASE+U Search CARBOXYPEPTIDASE+U
3 THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR 94 69% 13% 81 Search THROMBIN+ACTIVATABLE+FIBRINOLYSIS+INHIBITOR Search THROMBIN+ACTIVATABLE+FIBRINOLYSIS+INHIBITOR
4 PROCARBOXYPEPTIDASE U 26 100% 2% 11 Search PROCARBOXYPEPTIDASE+U Search PROCARBOXYPEPTIDASE+U
5 THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR TAFI 25 73% 3% 19 Search THROMBIN+ACTIVATABLE+FIBRINOLYSIS+INHIBITOR+TAFI Search THROMBIN+ACTIVATABLE+FIBRINOLYSIS+INHIBITOR+TAFI
6 TAFIA 15 82% 1% 9 Search TAFIA Search TAFIA
7 CARBOXYPEPTIDASE R 14 100% 1% 7 Search CARBOXYPEPTIDASE+R Search CARBOXYPEPTIDASE+R
8 PROCPU 11 100% 1% 6 Search PROCPU Search PROCPU
9 THROMBIN ACTIVABLE FIBRINOLYSIS INHIBITOR 8 100% 1% 5 Search THROMBIN+ACTIVABLE+FIBRINOLYSIS+INHIBITOR Search THROMBIN+ACTIVABLE+FIBRINOLYSIS+INHIBITOR
10 CLOT LYSIS TIME 5 47% 1% 8 Search CLOT+LYSIS+TIME Search CLOT+LYSIS+TIME

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 PLASMA PROCARBOXYPEPTIDASE B 160 84% 14% 88
2 TAFI 125 65% 19% 119
3 JUGULAR VEIN THROMBOLYSIS 97 90% 7% 43
4 CARBOXYPEPTIDASE B 61 63% 10% 62
5 PROCARBOXYPEPTIDASE U 55 77% 6% 37
6 PROCARBOXYPEPTIDASE B 50 60% 9% 55
7 PLASMA CARBOXYPEPTIDASE 50 86% 4% 25
8 ANTIFIBRINOLYTIC ACTIVITY 45 90% 3% 19
9 ACTIVATABLE FIBRINOLYSIS INHIBITOR 40 44% 11% 69
10 ARGININE CARBOXYPEPTIDASE 38 89% 3% 17

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Insights into thrombin activatable fibrinolysis inhibitor function and regulation 2013 11 102 88%
Thrombin activatable fibrinolysis inhibitor: At the nexus of fibrinolysis and inflammation 2012 17 47 79%
Curiouser and curiouser: Recent advances in measurement of thrombin-activatable fibirinolysis inhibitor (TAFI) and in understanding its molecular genetics, gene regulation, and biological roles 2007 49 110 87%
What has been learnt from the thrombin-activatable fibrinolysis inhibitor-deficient mouse? 2010 30 52 67%
Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy? 2009 21 79 90%
Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, an unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysis 2006 72 83 60%
Thrombin activatable fibrinolysis inhibitor 2011 10 91 93%
Measurement of procarboxypeptidase U (TAFI) in human plasma: A laboratory challenge 2006 33 41 100%
A role for procarboxypepidase U (TAFI) in thrombosis 2007 26 97 81%
Carboxypeptidase U (TAFla): a metallocarboxypeptidase with a distinct role in haemostasis and a possible risk factor for thrombotic disease 2005 50 171 73%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 SECT GEN EXPT PATHOL 7 57% 1.3% 8
2 CLIN CHEM L25 4 75% 0.5% 3
3 THER EUT DIAGNOST ANTIBODIES 4 35% 1.4% 9
4 MOL CELLULAR PATHOPHYSIOL 3 35% 1.3% 8
5 HAEMATOL G03 647 2 29% 0.8% 5
6 INSERMU626 1 50% 0.3% 2
7 THROMBOSIS BIOL 1 27% 0.5% 3
8 AUTOIMMUNE DIS MED 1 50% 0.2% 1
9 BIOCHEM BIOL NUTR 1 50% 0.2% 1
10 CARDIOVASC METAB DISORDERS AREA 1 50% 0.2% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000208820 CARBOXYPEPTIDASE T//PROCARBOXYPEPTIDASE A//CALDECRIN
2 0.0000138001 PROLYLCARBOXYPEPTIDASE//PRCP//ANGIOTENSINASE C
3 0.0000114878 THROMBOMODULIN//SOLUBLE THROMBOMODULIN//PLASMA THROMBOMODULIN
4 0.0000101125 THROMBIN GENERATION//SYN SE BV//PHYS BIOCHEM BLOOD
5 0.0000094988 CLIN PATHOL BIOCHEM//ALPHA2 ANTIPLASMIN//TC 99M NC100668
6 0.0000084835 2 2 HYDROXYPROPANAMIDO BENZOIC ACID//2 5 DISUBSTITUTED DIOXACYCLOALKANES//PEPTIDE 6A
7 0.0000083768 SECT HEPATOBILIARY SURG LIVER TRANSPLANTAT//AMINO ACIDS THERAPEUTIC USE//LIVER DISEASES COMPLICATIONS
8 0.0000075768 UNITAT ANAT HUMANA EMBRIOL//UNITAT MED MATERNO FETAL//THROMBIN ANTITHROMBIN COMPLEXES
9 0.0000074649 ACQUIRED VON WILLEBRAND SYNDROME//ACQUIRED VON WILLEBRAND DISEASE//ACQUIRED VON WILLEBRANDS SYNDROME
10 0.0000070977 PLASMINOGEN ACTIVATOR INHIBITOR 1//PAI 1//FIBRINOLYSIS